RxDoctor Payments Data

Bridgette Franey

Family Medicine · Nashville, TNNPI 1417970831

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,019 of the $1,541 with a category attached, or 66.2%. Astrazeneca UK Limited accounts for 97.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,498 and has fallen 98.2% since, to $27 in 2023.

$1,541in general payments, 2019–2025

Across 12 payments — averaging $128.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$1K
  • Lemaitre Vascular, Inc.$27
  • Intercept Pharmaceuticals, Inc.$16
$2,038,696in research payments, 2019–2025

Across 39 payments — averaging $52,274 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.2M
  • Pfizer$540K
  • AstraZeneca$289K

What the payments were for

  • Travel & lodging$1,01966%
  • Food & beverage$52134%

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,541 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →